Recommendations
| Дозування | Ремарки | |
|---|---|---|
|
ceftriaxone intramuscular 500 mg single dose
|
SWAB remarks urethral/anal gonorrhoea |
| Дозування | Ремарки | |
|---|---|---|
|
1st choice
|
ceftriaxone intramuscular 500 mg single dose
|
|
|
1st choice alternative
|
amoxicillin oral 3000 mg single dose
|
SWAB remarks if ceftriaxone is contraindicated; guided by resistance pattern |
| Дозування | Ремарки | |
|---|---|---|
|
ciprofloxacin oral 500 mg single dose
|
SWAB remarks only if susceptibility to ciprofloxacin is proven |
|
|
azithromycin oral 2000 mg single dose
|
SWAB remarks follow-up required |
500 and 1000 mg ceftriaxone respectively dissolved in 2 ml and 3.5 ml lidocaine hydrochloride 10 mg/ml (1%) solution (pain prevention)
If ceftriaxone is not available, a good alternative is: cefotaxime 1000 mg intramuscular, single dose. Only if susceptibility is proven: ciprofloxacin 500 mg oral, single dose.
In cases of high clinical suspicion of gonococcal conjunctivitis (severe and acute purulent presentation) the patient should urgently (the same day) be seen by an ophthalmologist for microbiological diagnostics, treatment and to exclude gonococcal keratitis.
Disseminated infection: ceftriaxone IV 2000 mg once daily for 7 days; if susceptibility proven, after 3 days switch to ciprofloxacin oral 500 mg twice daily for 7 days
For treatment of gonococcal conjunctivitis, see 2.1 Conjunctivitis - unknown pathogen
For treatment of gonococcal arthritis, see 3.6 Septic arthritis - gonococci (Neisseria gonorrhoeae)